PDT Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

PDT Partners’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,460	Closed	-$755K	–	1073
2021 Q3	$755K	Buy	+37,460	New	+$1.03M	0.05%	398
2021 Q1	–	Sell	-19,905	Closed	-$439K	–	937
2020 Q4	$439K	Buy	+19,905	New	+$438K	0.03%	472
2020 Q1	–	Sell	-9,688	Closed	-$213K	–	910
2019 Q4	$213K	Buy	+9,688	New	+$195K	0.01%	633
2017 Q2	–	Sell	-25,300	Closed	-$86K	–	592
2017 Q1	$86K	Sell	25,300 -4,000	-14%	-$11.3K	﹤0.01%	463
2016 Q4	$84K	Buy	29,300 +4,100	+16%	+$14.6K	0.01%	491
2016 Q3	$148K	Buy	+25,200	New	+$88.3K	0.01%	451
2016 Q1	–	Sell	-19,833	Closed	-$235K	–	612
2015 Q4	$235K	Sell	19,833 -23,722	-54%	-$271K	0.03%	336
2015 Q3	$358K	Sell	43,555 -14,019	-24%	-$162K	0.01%	1005
2015 Q2	$803K	Buy	57,574 +44,274	+333%	+$812K	0.02%	805
2015 Q1	$320K	Buy	+13,300	New	+$299K	0.01%	1139

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

PDT Partners's DRNA Position: Q4 2021 in Review

PDT Partners sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 37,460 shares — an estimated $755K sold.

PDT Partners first reported a position in DRNA in Q1 2015 and held it in 10 quarters. The position peaked at $803K in Q2 2015. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

PDT Partners reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
PDT Partners sold 37,460 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $755K.
PDT Partners first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 10 quarters.
PDT Partners's Dicerna Pharmaceuticals, Inc. position peaked at $803K in Q2 2015.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.